Elevated CXCL10 levels have been reported in the CSF of ALL patients (21, 31) and have also been linked to advanced disease stage, metastasis, and poor prognosis in metastatic solid tumors (47, 49, 58, 83–86). This evidence concerns the gene CXCL10 and acute lymphoblastic leukemia.